Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: A systematic review and meta-analysis

International Journal of Impotence Research

Volumn 16, Issue 4, 2004, Pages 369-381

  Waldinger, M D ^a,b   Zwinderman, A H ^c   Schweitzer, D H ^d   Olivier, B ^b,e  

^a LEYENBURG HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d REINIER DE GRAAF HOSPITAL   (Netherlands)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Meta analysis; Paroxetine; Premature ejaculation; Serotonin; SSRI

Indexed keywords

ALFUZOSIN; AMITRIPTYLINE PLUS PERPHENAZINE; BENZOCAINE; CINCHOCAINE; CIPROFLOXACIN; CLOMIPRAMINE; CYPROTERONE ACETATE; FLUOXETINE; GUANETHIDINE; HYDROCORTISONE; IPRONIAZID; ISOCARBOXAZID; LIDOCAINE; LORAZEPAM; METOCLOPRAMIDE; OPIPRAMOL; PAPAVERINE; PAROXETINE; PHENOXYBENZAMINE; PHENTOLAMINE; PRILOCAINE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SULPIRIDE; TERAZOSIN; THIORIDAZINE; TRAZODONE;

CLINICAL TRIAL; DRUG EFFICACY; EJACULATION; EVIDENCE BASED MEDICINE; HUMAN; MALE; META ANALYSIS; METHODOLOGY; PATIENT SATISFACTION; PREMATURE EJACULATION; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SEXUAL BEHAVIOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CLOMIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EJACULATION; HUMANS; MALE; PAROXETINE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SINGLE-BLIND METHOD; SYMPATHOLYTICS;

EID: 4644265324     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901172     Document Type: Review

References (93)

1. Waldinger MD. The neurobiological approach to premature ejaculation (review article). J Urol 2002; 168: 2359-2367.
2. Waldinger MD, Olivier B. Selective serotonin reuptake inhibitors (SSRIs) and sexual side effects: differences in delaying ejaculation. In: Sacchetti E, Spano P (eds) Advances in Preclinical and Clinical Psychiatry, Vol I: Fluvoxamine: Established and Emerging Roles in Psychiatric Disorders. Excerpta Medica: Milan, Italy, 2000, pp 117-130.
3. Waldinger MD. Chapter 15: Rapid ejaculation. In: Levine SB, Risen CB, Althof SE (eds) Handbook of Clinical Sexuality for Mental Health Professionals. Brunner-Routledge: New York, 2003, pp 257-274.
4. Waldinger MD et al. The SSRIs fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology 2001; 160: 283-289.
5. Waldinger MD et al. Premature ejaculation and SSRI-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998; 92: 111-118.
6. Waldinger MD, Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol 1998; 13(Suppl 6): S27-S33.
7. Olivier B, van Oorschot R, Waldinger MD. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol 1998; 13(Suppl 6): S9-S14.
8. Waldinger MD et al. Familial occurrence of primary premature ejaculation. Psychiatr Genet 1998; 8: 37-40.
9. Waldinger MD. Lifelong premature ejaculation: from authority based to evidence based medicine. Br J Urol Int, 2004 (in press).
10. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Int J Psychiatry Clin Pract 1998; 2: 287-293.
11. Waldinger MD. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. J Impot Res 2003; 15: 309-313.
12. Moser A. Die Verwendung von Nupercainal in Geburtshilfe, Gynakologie und Eheberatung (German). Wien Med Wochnschr 1953; 103: 814-816.
13. Schöning FW. Behandlungsergebnisse bei Ejakulatio praecox mit opipramol (Insidon) (German). Z Haut-Geschl Kr 1972; 47: 135-140.
14. Wiederholt I. Behandlung der Ejaculatio Praecox mit einem Antiandrogen. (German). Psychiat Prax 1977; 4: 176-180.
15. Porto R. Essai en double aveugle de la clomipramine dans léjaculafion premature (French). Med Hygiene 1981; 39: 1249-1253.
16. Nielsen NP. L'ejaculazione precoce e il suo trattamento: nota preliminare sull'attivita' del caroxazone (Italian). Rass Studi Psichiatr 1981; 70: 1065-1080.
17. Giammusso B, Morgia G, Spampinato A, Motta M. La paroxetina nel trattamento dell'eiaculazione precoce. Arch Ital Urol Androl 1997; 69: 11-13.
18. Beretta G et al. Trattamento con un alfa-bloccante (fenossi-benzamina) della eiaculazione precoce (Italian). Minerva Urol Nefrol 1988; 40: 29-32.
19. Martinez Hurtado M, Gonzales Menendez R, Idelfonso Alavarez E, Goicolea Maiza S. La eyaculacion precoz: caracteristicas clinicas y respuesta al tratamiento con guanetidina (Spanish). Rev Hosp Psiquiatr Habana 1981; 22: 105-116.
20. Pico Costero J, Abreu de la Torre C, Roque Banos YL. Eyaculacion precoz. Tratamiento con tioridacina (Spanish). Rev Hosp Psiquiatr Habana 1986; 27: 277-280.
21. De Almeida Claro J et al. Experiencia brasileira com a trazodona no tratamento da ejaculacao precoce (Portugese). Rev Brasil Med 2000; 57: 931-934.
22. Hronek J, Kolomaznik M. Farmakoterapie prekotneho prubehu pohlavniho styku. (Czech). Cesk Psychiatr 1986; 82: 303-306.
23. Kolomaznik M, Hronek J, Kolomaznik J, Kufner P. Sertralin v leche ejaculatio praecox: Intermitentne nebo kontinualne? (Czech). Psychiatr C'slo 1998; 2: 244-246.
24. Kolomaznik M et al. Fluoxetin v lecbe ejaculatio praecox (Czech). Psychiatrie 2002; 6: 6-9.
25. Kery S, Kozma A. Ejaculatio praecox citalopram kezelese (Hungarian). Magyar Urol 1995; 7: 359-364.
26. Choi HK, Xin ZC, Cho IR. The effect of herb cream (SS-cream) on premature ejaculation. J Korean Androl Soc 1993; 11: 99-105.
27. Xin ZC, Seong DH, Minn YG, Choi HK. A double blind clinical trial of SS-cream on premature ejaculation. Korean J Urol 1994; 35: 533-537.
28. Bishop YMM. The δ-method for calculating asymptomatic distributions. In: Bishop YMM, Fienberg SE, Holland PW (eds). Discrete Multivariate Analysis: Theory and Practice. The MIT Press: Cambridge, MA, and London, England, 1975, pp 486-502.
29. Schapiro B. Premature ejaculation, a review of 1130 cases. J Urol 1943; 50: 374-379.
30. Aycock L. The medical management of premature ejaculation. J Urol 1949; 62: 361-362.
31. Damrau F. Premature ejaculation: use of ethyl aminobenzoate to prolong coitus. J Urol 1963; 89: 936-939.
32. Berkovitch M, Keresteci AG, Koren G. Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation. J Urol 1995; 154: 1360-1361.
33. Xin ZC, Choi YD, Lee SH, Choi HK. Efficacy of a topical agent SS-cream in the treatment of premature ejaculation: preliminary clinical studies. Yonsei Med J 1997; 38: 91-95.
34. Choi HK et al. Safety and efficacy study with various doses of SS-cream in patients with premature ejaculation in a double-blind, randomised, placebo controlled clinical study. Int J Impot Res 1999; 11: 261-264.
35. Choi HK et al. Clinical study of SS-cream in patients with lifelong premature ejaculation. Urology 2000; 55: 257-261.
36. Slob AK, van Berkel A, van der Werff ten Bosch JJ. Premature ejaculation treated by local penile anaesthesia in an uncontrolled clinical replication study. J Sex Res 2000; 37: 244-247.
37. Atikeler MK, Gecit I, Senol FA. Optimum usage of prilocaine-lidocaine cream in premature ejaculation. Andrologia 2002; 34: 356-359.
38. Bartova D, Bouchal M. Thioridazine treatment of ejaculatio praecox. Act Nerv Super (Praha) 1965; 7: 244-245.
39. Mellgren A. Treatment of ejaculatio praecox with thioridazine. Psychother Psychosom 1967; 15: 454-460.
40. Falaschi P et al. Brain dopamine and premature ejaculation: results of treatment with dopamine antagonists. In: Gessa GL, Corsini GU (eds) Apomorphine and Other Dopaminomimetics. Vol. I: Basic Pharmacology. Raven Press: New York, 1981, pp 117-121.
41. Wabrek AJ. Effect of metoclopramine on ejaculatory threshold in a group of premature ejaculators. Neurourol Urodyn 1984; 3: 155-161.
42. Greco E, Polonio-Balbi P, Speranza JC. Levosulpiride: a new solution for premature ejaculation. Int J Impot Res 2002; 14: 308-309.
43. Bennett D. Treatment of ejaculatio praecox with monoamine-oxidase inhibitors (letter). Lancet 1961; 9: 1309.
44. Shilon M, Paz GF, Hommonai ZT. The use of phenoxybenzamine treatment in premature ejaculation. Fertil Steril 1984; 42: 659-661.
45. Beretta G, Chelo E, Fanciullacci F, Zanollo A. Effect of an alpha-blocking agent (phenoxybenzamine) in the management of premature ejaculation. Acta Eur Fertil 1986; 17: 43-45.
46. Cavallini G. Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy. Eur Urol 1995; 28: 126-130.
47. Boneff AN. Topical treatment of chronic prostatitis and premature ejaculation. Int Urol Nephrol 1971; 4: 183-186.
48. Brown AJ. Ciprofloxacin as cure of premature ejaculation (case report). J Sex Marital Ther 2000; 26: 351-352.
49. Cooper AJ, Magnus RV. A clinical trial of the beta blocker propranolol in premature ejaculation. J Psychosom Res 1984; 28: 331-336.
50. Segraves RT. Treatment of premature ejaculation with lorazepam (letter). Am J Psychiatry 1987; 144: 1240.
51. Fein RL. Intracavernous medication for treatment of premature ejaculation. Urology 1990; 35: 301-303.
52. Eaton H. Clomipramine in the treatment of premature ejaculation. J Int Med Res 1973; 1: 432-434.
53. Goodman RE. An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J Int Med Res Suppl 1980; 3: 53-59.
54. Girgis SM, El-Haggen S, El-Hermouzy S. A double-blind trial of clomipramine in premature ejaculation. Andrologia 1982; 14: 364-368.
55. Assalian P. Clomipramine in the treatment of premature ejaculation. J Sex Res 1988; 24: 213-215.
56. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomised, placebo-controlled study. Am J Psychiatry 1994; 151: 1377-1379.
57. Althof SE et al. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995; 56: 402-407.
58. Mendels J, Camera A, Sikes C. Sertraline treatment for premature ejaculation. J Clin Psychopharmacol 1995; 15: 341-346.
59. Montorsi F et al. Clomipramine for premature ejaculation: a randomized, double blind, placebo controlled study. Acta Urol Ital 1995; 1: 5-6.
60. Kara H et al. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind, placebo controlled study. J Urol 1996; 156: 1631-1632.
61. Ludovico GM et al. Paroxetine in the treatment of premature ejaculation. Br J Urol 1996; 78: 881-882.
62. Lee HS, Song DH, Kim CH, Choi HK. An open clinical trial of fluoxetine in the treatment of premature ejaculation. J Clin Psychopharmacol 1996; 16: 379-382.
63. Waldinger MD, Hengeveld MW, Zwinderman AH. Ejaculation retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomised, dose-response study. Br J Urol 1997; 79: 592-595.
64. Raju GAR et al. Evaluation of fluoxetine in premature ejaculation. Indian J Pharmacol 1997; 29: 204-205.
65. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. J Clin Psychopharmacol 1998; 18: 274-281.
66. Haensel SM, Klem TMAL, Hop WCJ, Slob AK. Fluoxetine and premature ejaculation: a double-blind, crossover, placebo-controlled study. J Clin Psychopharmacol 1998; 18: 72-77.
67. Biri H et al. Sertraline in the treatment of premature ejaculation: a double-blind placebo controlled study. Int Urol Nephrol 1998; 30: 611-615.
68. McMahon CG. Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol 1998; 159: 1935-1938.
69. McMahon CG. Treatment of premature ejaculation with sertraline hydrochloride. Int J Impot Res 1998; 10: 181-184.
70. Kim SC, Seo KK. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study. J Urol 1998; 159: 425-427.
71. Balbay MD et al. Treatment of premature ejaculation with sertralin. Int Urol Nephrol 1998; 30: 81-83.
72. Basar MM et al. Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation. Arch Esp Urol 1999; 52: 1.008-1.011.
73. Yilmaz U et al. The effects of fluoxetine on several neurophysiological variables in patients with premature ejaculation. J Urol 1999; 161: 107-111.
74. McMahon CG, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res 1999; 11: 241-245.
75. Atan A, Basar MM, Aydoganli L. Comparison of the efficacy of fluoxetine alone vs fluoxetine plus local lidocaine ointment in the treatment of premature ejaculation. Arch Esp Urol 2000; 53: 856-858.
76. Rowland DL, De Gouveia Brazao CA, Slob AK. Effective daily treatment with clomipramine in men with premature ejaculation when 25 mg (as required) is ineffective. BJU Int 2001; 87: 357-360.
77. Waldinger MD, Zwinderman AH, Olivier B. Antide-pressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J Clin Psychopharmacol 2001; 21: 293-297.
78. Waldinger MD, Zwinderman AH, Olivier B. SSRIs and ejaculation: a double-blind, randomised, fixed-dose study with paroxetine and citalopram. J Clin Psychopharmacol 2001; 21: 556-560.
79. Waldinger MD, Zwinderman AH, Olivier B. Antidepressants and ejaculation: a double-blind, randomised, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol 2003; 23: 467-470.
80. Novaretti JPT, Pompeo ACL, Arap S. Selective serotonin uptake inhibitor in the treatment of premature ejaculation. Brazil J Urol 2002; 28: 116-122.
81. Atmaca M, Kuloglu M, Tezcan E, Semercioz A. The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Int J Impot Res 2002; 14: 502-505.
82. Segraves RT, Saran A, Segraves K, Maguire E. Clomipramine vs placebo in the treatment of premature ejaculation: a pilot study. J Sex Marital Ther 1993; 19: 198-200.
83. Haensel SM, Rowland DL, Kallan KTHK, Slob AK. Clomipramine and sexual function in men with premature ejaculation and controls. J Urol 1996; 156: 1310-1315.
84. Strassberg DS et al. Clomipramine in the treatment of rapid (premature) ejaculation. J Sex Marital Ther 1999; 25: 89-101.
85. Kim SW, Paick J-S. Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation. Urology 1999; 54: 544-547.
86. McMahon C, Touma K. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind, placebo-controlled, crossover studies. J Urol 1999; 161: 1826-1830.
87. Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001; 13: 41-45.
88. Chia SJ. Management of premature ejaculation - a comparison of treatment outcome in patients with and without erectile dysfunction. Int J Androl 2002; 25: 301-305.
89. Salonia A et al. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002; 168: 2486-2489.
90. Riley AJ, Riley EJ. Amitriptyline-perphenazine and the squeeze technique in premature ejaculation. J Pharmacother 1979; 2: 136-140.
91. Xin ZC et al. Penile sensitivity in patients with primary premature ejaculation. J Urol 1996; 156: 979-981.
92. Xin ZC, Choi YD, Rha KH, Choi HK. Somatosensory evoked potentials in patients with premature ejaculation. J Urol 1997; 158: 451-455.
93. Truitt WA, Coolen LM. Identification of a potential ejaculation generator in the spinal cord. Science 2002; 297: 1566-1569.